Order Article Reprints

Chen T-T, Lin C-C, Lo W-J, Hsieh C-Y, Lein M-Y, Lin C-H, Lin C-Y, Bai L-Y, Chiu C-F, Yeh S-P. Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid Leukemia. Cancers. 2024; 16(6):1082. https://doi.org/10.3390/cancers16061082

Chen, Tzu-Ting, Ching-Chan Lin, Wen-Jyi Lo, Ching-Yun Hsieh, Ming-Yu Lein, Che-Hung Lin, Chen-Yuan Lin, Li-Yuan Bai, Chang-Fang Chiu, and Su-Peng Yeh. 2024. "Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid Leukemia" Cancers 16, no. 6: 1082. https://doi.org/10.3390/cancers16061082

Chen, T.-T., Lin, C.-C., Lo, W.-J., Hsieh, C.-Y., Lein, M.-Y., Lin, C.-H., Lin, C.-Y., Bai, L.-Y., Chiu, C.-F., & Yeh, S.-P. (2024). Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid Leukemia. Cancers, 16(6), 1082. https://doi.org/10.3390/cancers16061082